Assobiomedica's healthcare efficiency views prove timely, as Italy embraces austerity
This article was originally published in Clinica
Executive Summary
The Italian medtech industry has advocated increasing the cost-efficiency of the health system. The suggestions are well timed; this week the Italian government announced austerity measures worth €24bn over 2011-12, or about 1.6% of GDP.